Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Central GLP-1 receptor activation modulates cocaine-evoked phasic dopamine signaling in the nucleus accumbens core
Samantha M. Fortin, Mitchell F. Roitman
Physiology & Behavior (2017) Vol. 176, pp. 17-25
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

The dopamine motive system: implications for drug and food addiction
Nora D. Volkow, Roy A. Wise, Rubén Baler
Nature reviews. Neuroscience (2017) Vol. 18, Iss. 12, pp. 741-752
Closed Access | Times Cited: 807
The role of glucagon‐like peptide 1 (GLP‐1) in addictive disorders
Mette Kruse Klausen, Morgane Thomsen, Gitta Wörtwein, et al.
British Journal of Pharmacology (2021) Vol. 179, Iss. 4, pp. 625-641
Open Access | Times Cited: 110
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
Vicky Chuong, Mehdi Farokhnia, Sophia Khom, et al.
JCI Insight (2023) Vol. 8, Iss. 12
Open Access | Times Cited: 84
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Nicholas K. Smith, Troy A. Hackett, Aurelio Galli, et al.
Neurochemistry International (2019) Vol. 128, pp. 94-105
Open Access | Times Cited: 113
From Stress to Anhedonia: Molecular Processes through Functional Circuits
Colin H. Stanton, Avram J. Holmes, Steve W. C. Chang, et al.
Trends in Neurosciences (2018) Vol. 42, Iss. 1, pp. 23-42
Open Access | Times Cited: 104
Can GLP-1 Be a Target for Reward System Related Disorders? A Qualitative Synthesis and Systematic Review Analysis of Studies on Palatable Food, Drugs of Abuse, and Alcohol
Candan Yasemin Eren, Arya Yigit, Ramazan Efe Dogruoz, et al.
Frontiers in Behavioral Neuroscience (2021) Vol. 14
Open Access | Times Cited: 72
The therapeutic potential of glucagon-like peptide-1 for persons with addictions based on findings from preclinical and clinical studies
Elisabet Jerlhag
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 37
IUPHAR review – Glucagon-like peptide-1 (GLP-1) and substance use disorders: An emerging pharmacotherapeutic target
Nicolaus Bruns, Elizabeth H. Tressler, Leandro F. Vendruscolo, et al.
Pharmacological Research (2024) Vol. 207, pp. 107312-107312
Open Access | Times Cited: 10
An analysis on the role of glucagon-like peptide-1 receptor agonists in cognitive and mental health disorders
Riccardo De Giorgi, Ana Ghenciulescu, Oliwia Dziwisz, et al.
Nature Mental Health (2025)
Open Access | Times Cited: 1
An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking
R. Merkel, Nicole S. Hernandez, Vanessa Weir, et al.
Science Advances (2025) Vol. 11, Iss. 9
Open Access | Times Cited: 1
Gut-brain axis and addictive disorders: A review with focus on alcohol and drugs of abuse
Elisabet Jerlhag
Pharmacology & Therapeutics (2018) Vol. 196, pp. 1-14
Open Access | Times Cited: 79
Vagal Interoceptive Modulation of Motivated Behavior
James W. Maniscalco, Linda Rinaman
Physiology (2018) Vol. 33, Iss. 2, pp. 151-167
Open Access | Times Cited: 72
The glucagon-like peptide 1 receptor agonist Exendin-4 decreases relapse-like drinking in socially housed mice
Morgane Thomsen, Ditte Dencker, Gitta Wörtwein, et al.
Pharmacology Biochemistry and Behavior (2017) Vol. 160, pp. 14-20
Closed Access | Times Cited: 67
Long-Acting Glucagon-Like Peptide-1 Receptor Agonists Suppress Voluntary Alcohol Intake in Male Wistar Rats
Vincent Marty, Mehdi Farokhnia, Joseph J. Munier, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 57
Targeting GLP-1 receptors to reduce nicotine use disorder: Preclinical and clinical evidence
Rae J. Herman, Heath D. Schmidt
Physiology & Behavior (2024) Vol. 281, pp. 114565-114565
Open Access | Times Cited: 6
Activation of glucagon‐like peptide‐1 receptors in the nucleus accumbens attenuates cocaine seeking in rats
Nicole S. Hernandez, Bernadette O’Donovan, Pavel I. Ortinski, et al.
Addiction Biology (2017) Vol. 24, Iss. 2, pp. 170-181
Open Access | Times Cited: 61
Parallels and Overlap: The Integration of Homeostatic Signals by Mesolimbic Dopamine Neurons
Ted M. Hsu, James E. McCutcheon, Mitchell F. Roitman
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 51
Glucagon-Like Peptide-1 Receptor Agonist Treatment Does Not Reduce Abuse-Related Effects of Opioid Drugs
Annika Billefeld Bornebusch, Anders Fink‐Jensen, Gitta Wörtwein, et al.
eNeuro (2019) Vol. 6, Iss. 2, pp. ENEURO.0443-18.2019
Open Access | Times Cited: 47
Gut peptide regulation of food intake – evidence for the modulation of hedonic feeding
Orla Woodward, Fiona M. Gribble, Frank Reimann, et al.
The Journal of Physiology (2021) Vol. 600, Iss. 5, pp. 1053-1078
Open Access | Times Cited: 33
Metabolic hormone action in the VTA: Reward-directed behavior and mechanistic insights
Caroline E. Geisler, Matthew R. Hayes
Physiology & Behavior (2023) Vol. 268, pp. 114236-114236
Open Access | Times Cited: 16
GLP-1 signaling and alcohol-mediated behaviors; preclinical and clinical evidence
Elisabet Jerlhag
Neuropharmacology (2018) Vol. 136, pp. 343-349
Open Access | Times Cited: 46
Central GLP-1 receptors: Novel molecular targets for cocaine use disorder
Nicole S. Hernandez, Heath D. Schmidt
Physiology & Behavior (2019) Vol. 206, pp. 93-105
Open Access | Times Cited: 42
Phasic dopamine responses to a food-predictive cue are suppressed by the glucagon-like peptide-1 receptor agonist Exendin-4
Vaibhav Konanur, Ted M. Hsu, Scott E. Kanoski, et al.
Physiology & Behavior (2019) Vol. 215, pp. 112771-112771
Open Access | Times Cited: 42
Cognitive dysfunction and metabolic comorbidities in mood disorders: A repurposing opportunity for glucagon-like peptide 1 receptor agonists?
Rodrigo B. Mansur, Yena Lee, Mehala Subramaniapillai, et al.
Neuropharmacology (2018) Vol. 136, pp. 335-342
Closed Access | Times Cited: 40
GLP-1 receptor signaling in the laterodorsal tegmental nucleus attenuates cocaine seeking by activating GABAergic circuits that project to the VTA
Nicole S. Hernandez, Vanessa Weir, Kael Ragnini, et al.
Molecular Psychiatry (2020) Vol. 26, Iss. 8, pp. 4394-4408
Open Access | Times Cited: 35
Page 1 - Next Page

Scroll to top